--- schema_version: "secwatch.filing_event.v1" accession: "0001193125-24-127561" form_type: "8-K" ticker: "HLF" cik: "0001180262" company_name: "HERBALIFE LTD." filed_at: "2024-05-01T23:59:59+00:00" generated_at: "2026-06-03T02:12:18.587967+00:00" event_type: "earnings" sentiment: "positive" materiality_score: 0.75 calibrated_materiality_score: 0.75 confidence: "high" source: SEC EDGAR --- # Herbalife Q1 net sales $1.3B (+1% YoY); raises full-year adjusted EBITDA guidance ## Summary - Q1 net sales $1.3B (+1% YoY, +2.4% cc); net income $24.3M; adjusted diluted EPS $0.49; adjusted EBITDA $138.3M above guidance. - Restructuring plan: at least $80M annual savings by 2025, $40M in 2024; $17M pre-tax charge recognized in SG&A. - Completed $1.6B senior secured refinancing on April 12. - Full-year 2024 guidance: raised adjusted EBITDA, reduced capex, reaffirmed net sales; Q2 guidance provided. - Shareholders approved amendment to 2023 Stock Incentive Plan, increasing shares available (35.4M for, 31.3M against). ## SEC filing metadata - accession: 0001193125-24-127561 - form_type: 8-K - ticker: HLF - cik: 0001180262 - company_name: HERBALIFE LTD. - filed_at: 2024-05-01T23:59:59+00:00 - event_type: earnings - sentiment: positive - materiality_score: 0.75 - calibrated_materiality_score: 0.75 - confidence: high - sec_items: 2.02, 5.07, 7.01, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1180262/000119312524127561/0001193125-24-127561-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1180262/000119312524127561/d814921d8k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001193125-24-127561 - JSON: https://secwatch.observer/filing/0001193125-24-127561.json - Plain text: https://secwatch.observer/filing/0001193125-24-127561.txt ## Key facts - Earnings Releases HERBALIFE LTD. reported first quarter ended March 31, 2024 results: revenue $1.3 billion, net income $24.3 million, EPS $0.24. Guidance reaffirmed. - Period: first quarter ended March 31, 2024 - Revenue: $1.3 billion - Net income: $24.3 million - EPS: $0.24 - Guidance: reaffirmed - Result: reported results source text: the first quarter ended March 31, 2024: Highlights First Quarter 2024 • Achieved year-over-year net sales growth on both reported and constant currency basis 2 ○ Net sales of $1.3 billion, up 1.0% vs. 1Q ’23, in-line with guidance; on constant currency basis 2 up 2.4% • Net income of $24.3 million • Adjusted EBITDA 1 of $138.3 million exceeds guidance; adjusted evidence_url: https://www.sec.gov/Archives/edgar/data/1180262/000119312524127561/0001193125-24-127561-index.htm - Shareholder Votes HERBALIFE LTD. shareholders approved Election of Directors at the 2024-04-25 meeting. - Proposal: director election - Outcome: passed - Meeting: 2024-04-25 source text: Proposal 1: Election of Directors. Ten board nominees for director were elected by a majority of the votes cast with respect to each nominee to serve until the 2025 annual general meeting of shareholders of the Company or until their successors are duly elected and qualified. The voting results are as follows: For Against Abstain Broker Non-votes Michael O. Johnson 66,079,357 582,448 19,226 9,921,498 Richard H. Carmona 65,747,055 915,113 18,863 9,921,498 Celine Del Genes 57,068,905 385,052 9,227,074 9,921,498 Sophie L’Hélias 66,183,554 474,934 22,543 9,921,498 Alan W. LeFevre 66,131,815 525,590 23,626 9,921,498 Michael J. Levitt 66,377,766 281,423 21,842 9,921,498 Rodica Macadrai 66,113,949 543,286 23,796 9,921,498 Juan Miguel Mendoza 66,129,687 527,738 23,606 9,921,498 Don Mulligan 56,978,797 474,785 9,227,449 9,921,498 Maria Otero 56,877,207 577,611 9,226,213 9,921,498 evidence_url: https://www.sec.gov/Archives/edgar/data/1180262/000119312524127561/0001193125-24-127561-index.htm - Shareholder Votes HERBALIFE LTD. shareholders approved Ratify, on an advisory basis, the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2024 at the 2024-04-25 meeting. - Proposal: auditor ratification - Outcome: passed - Meeting: 2024-04-25 source text: Proposal 4: Ratify, on an advisory basis, the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2024. The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2024 was ratified. The voting results are as follows: For Against Abstain Broker Non-votes 75,553,956 1,040,485 8,088 0 evidence_url: https://www.sec.gov/Archives/edgar/data/1180262/000119312524127561/0001193125-24-127561-index.htm - Shareholder Votes HERBALIFE LTD. shareholders approved Approve an amendment and restatement of the Company’s 2023 Stock Incentive Plan to increase the number of Common Shares available for issuance under such plan at the 2024-04-25 meeting. - Proposal: equity plan - Outcome: passed - Meeting: 2024-04-25 source text: Proposal 3: Approve an amendment and restatement of the Company’s 2023 Stock Incentive Plan to increase the number of Common Shares available for issuance under such plan. The amendment and restatement of the Company’s 2023 Stock Incentive Plan to increase the number of Common Shares available for issuance under such plan was approved. The voting results are as follows: For Against Abstain Broker Non-votes 35,401,164 31,266,178 13,689 9,921,498 evidence_url: https://www.sec.gov/Archives/edgar/data/1180262/000119312524127561/0001193125-24-127561-index.htm - Shareholder Votes HERBALIFE LTD. shareholders approved Approve, on an advisory basis, the compensation of the Company’s named executive officers at the 2024-04-25 meeting. - Proposal: say on pay - Outcome: passed - Meeting: 2024-04-25 source text: Proposal 2: Approve, on an advisory basis, the compensation of the Company’s named executive officers. The advisory resolution to approve the compensation of the named executive officers was approved. The voting results are as follows: For Against Abstain Broker Non-votes 55,103,969 2,345,635 9,231,427 9,921,498 evidence_url: https://www.sec.gov/Archives/edgar/data/1180262/000119312524127561/0001193125-24-127561-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.